Mountain View, California
United States
133
2025-06-19
The entities that hold a legal rights for patent applications filed by inventor Ibrahim Prabha N.:
Prabha N. Ibrahim from Mountain View, US has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#2 | 2023-09-07Compounds and methods for kinase modulation, and indications therefor
#3 | 2022-11-10Heterocyclic compounds and uses thereof
#4 | 2022-06-16FORMULATIONS OF A COMPOUND MODULATING KINASES
#5 | 2022-05-19SOLID FORMS OF A COMPOUND MODULATING KINASES
#6 | 2022-03-17SOLID FORMS OF A COMPOUND FOR MODULATING KINASES
#7 | 2021-11-18COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#8 | 2021-11-11COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#9 | 2020-10-29Heterocyclic compounds and uses thereof
#10 | 2020-09-24SOLID FORMS OF A COMPOUND FOR MODULATING KINASES
#11 | 2020-01-09Formulations of a compound modulating kinases
#12 | 2019-12-05Heterocyclic compounds and uses thereof
#13 | 2019-11-07Formulations of a compound modulating kinases
#14 | 2019-11-07Synthesis of a compound that modulates kinases
#15 | 2019-08-29COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR
#16 | 2019-08-08COMPOSITIONS AND USES THEREOF
#17 | 2019-07-11COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#18 | 2019-06-13Compounds and methods for kinase modulation, and indications therefor
#19 | 2019-05-30Solid forms of a compound for modulating kinases
#20 | 2019-05-02Formulations of a compound modulating kinases
#21 | 2019-04-25Solid forms of a compound modulating kinases
#22 | 2019-01-31Formulations of a compound modulating kinases
#23 | 2018-11-15Heterocyclic compounds and uses thereof
#24 | 2018-10-25Synthesis of a compound that modulates kinases
#25 | 2018-04-26COMPOSITIONS AND USES THEREOF
#26 | 2018-04-26COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#27 | 2018-04-12Compounds for kinase modulation, and indications therefor
#28 | 2018-03-01Kinase modulation, and indications therefor
#29 | 2018-02-01Solid forms of a compound modulating kinases
#30 | 2018-01-04Synthesis of heterocyclic compounds
#31 | 2017-12-21Heterocyclic compounds and uses thereof
#32 | 2017-12-07Compounds and methods for kinase modulation, and indications therefor
#33 | 2017-11-23Synthesis of a compound that modulates kinases
#34 | 2017-11-09Heterocyclic compounds and uses thereof
#35 | 2017-11-09COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#36 | 2017-10-05COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#37 | 2017-09-21Compounds and methods for kinase modulation, and indications therefor
#38 | 2017-08-31COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR
#39 | 2017-06-08Compounds and methods for kinase modulation, and indications therefor
#40 | 2017-06-08Compounds and methods for kinase modulation, and indications therefor
#41 | 2017-03-23Heterocyclic compounds and uses thereof
#42 | 2017-03-02Compounds and methods for kinase modulation, and indications therefor
#43 | 2016-12-08Compositions and uses thereof
#44 | 2016-11-24Synthesis of heterocyclic compounds
#45 | 2016-11-24Solid forms of a compound for modulating kinases
#46 | 2016-11-24Kinase modulation, and indications therefor
#47 | 2016-11-10Synthesis of a compound that modulates kinases
#48 | 2016-11-10Solid forms of a compound modulating kinases
#49 | 2016-08-25Kinase modulation, and indications therefor
#50 | 2016-06-23COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#51 | 2016-06-16Compounds and methods for kinase modulation, and indications therefor
#52 | 2015-12-24Synthesis of heterocyclic compounds
#53 | 2015-10-15COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#54 | 2015-09-24Compounds modulating c-fms and/or c-kit activity and uses therefor
#55 | 2015-07-02Compounds and methods for kinase modulation, and indications therefor
#56 | 2015-06-18Compounds and methods for kinase modulation, and indications therefor
#57 | 2015-05-14Heterocyclic compounds and uses thereof
#58 | 2015-03-19Compounds and methods for kinase modulation, and indications therefor
#59 | 2014-12-04Compounds for kinase modulation, and indications therefor
#60 | 2014-10-09COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#61 | 2014-09-25Compounds and methods for kinase modulation, and indications therefor
#62 | 2014-08-28Compounds modulating c-fms and/or c-kit activity and uses therefor
#63 | 2014-07-31Compounds and methods for kinase modulation, and indications therefor
#64 | 2014-05-08Compounds and methods for kinase modulation, and indications therefor
#65 | 2014-04-03Synthesis of heterocyclic compounds
#66 | 2014-02-13Compounds and methods for kinase modulation, and indications therefor
#67 | 2014-02-06Solid forms of a pharmaceutically active substance
#68 | 2014-02-06COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#69 | 2014-02-06Kinase modulation, and indications therefor
#70 | 2013-11-14COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#71 | 2013-10-17Kinase modulation and indications therefor
#72 | 2013-10-03COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#73 | 2013-09-12COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#74 | 2013-07-11Compounds modulating c-fms and/or c-kit activity and uses therefor
#75 | 2013-05-16A2B ADENOSINE RECEPTOR ANTAGONISTS
#76 | 2012-12-06Compounds modulating c-fms and/or c-kit activity and uses therefor
#77 | 2012-09-27COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#78 | 2012-06-28COMPOUNDS AND USES THEREOF
#79 | 2012-06-28Compounds and methods for kinase modulation, and indications therefor
#80 | 2012-05-17SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS
#81 | 2012-03-29ZAP-70 active compounds
#82 | 2012-03-01COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#83 | 2012-01-26Compounds and methods for kinase modulation, and indications therefor
#84 | 2012-01-19PPAR ACTIVE COMPOUNDS
#85 | 2011-10-27Compounds and methods for kinase modulation, and indications therefor
#86 | 2011-09-22Compounds modulating c-fms and/or c-kit activity
#87 | 2011-07-28COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#88 | 2011-07-07COMPOUNDS MODULATING C-KIT AND C-FMS ACTIVITY AND USES THEREFOR
#89 | 2011-06-23Compounds and methods for kinase modulation, and indications therefor
#90 | 2011-05-12COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#91 | 2011-04-21COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#92 | 2011-03-10Compounds and methods for kinase modulation, and indications therefor
#93 | 2010-12-09Compositions and uses thereof
#94 | 2010-11-11Pyrrolo[2,3-]pyridine kinase inhibitors
#95 | 2010-11-11Compounds and methods for kinase modulation, and indications therefor
#96 | 2010-10-07Compounds and methods for kinase modulation, and indications therefor
#97 | 2010-09-30Compounds and methods for kinase modulation, and indications therefor
#98 | 2010-09-16Compounds and uses thereof
#99 | 2010-08-19PPAR active compounds
#100 | 2010-07-29COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
249281 ⎘